New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation
- 1 August 2001
- journal article
- review article
- Published by Elsevier
- Vol. 159 (2) , 387-397
- https://doi.org/10.1016/s0002-9440(10)61708-7
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
This publication has 137 references indexed in Scilit:
- Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicinOncogene, 2001
- Expression of Bcl-XL Restores Cell Survival, but Not Proliferation and Effector Differentiation, in Cd28-Deficient T LymphocytesThe Journal of Experimental Medicine, 2000
- p300/CBP-Dependent and -Independent Transcriptional Interference between NF-κB RelA and p53Biochemical and Biophysical Research Communications, 2000
- The transcription factor NF-κB: control of oncogenesis and cancer therapy resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2000
- The Hallmarks of CancerCell, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategiesSurgical Oncology, 1999
- NF-κB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2Oncogene, 1999
- Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-κBOncogene, 1997
- t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: A review of 23 casesCancer Genetics and Cytogenetics, 1997